BJC reports

Evaluating the significance of combining PD-L1 and TILs as biomarkers in non-small cell lung cancer patients treated with immunotherapy: a systematic review.

Pub Date : 2025-09-22 DOI: 10.1038/s44276-025-00174-x Y Derraze, S M S Hashemi, E B Ulas, K A Ziesemer, B Lissenberg-Witte, T Radonic, I Bahce

Treatment with checkpoint inhibitors for unresectable non-metastatic mismatch repair deficient intestinal cancer; a case series.

Pub Date : 2025-09-22 DOI: 10.1038/s44276-025-00171-0 O J A Figaroa, I T Spaanderman, R S A Goedegebuure, G M Cirkel, F J F Jeurissen, G J Creemers, A D Bins, J Tuynman, T E Buffart

Observation of PICALM::MLLT10-rearrangement and coincidental EZH2 mutations in a patient with acute myeloid leukemia: A case report and review of the literature.

Pub Date : 2025-09-22 DOI: 10.1038/s44276-025-00175-w Christian Rausch, Ulrike Bacher, Joelle Tchinda, Michèle Hoffmann, Katja Seipel, Thomas Pabst